MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Comparison of cognitive , affective and autonomic functions in parkinson’s disease patients with and without freezing of gait and its correlation with PET/CT

    K. Harisankar, S. Mehta, R. Kumar, M. Mohanty, S. Singh, N. Balaini, V. Lal (CHANDIGARH, India)

    Objective: To study and compare the cognitive, affective and autonomic domains in Parkinson’s disease patients with and without freezing of gait and to correlate with…
  • 2023 International Congress

    The effect of peptic ulcer disease on Parkinson’s disease

    T. Abali, AV. Karacan, S. Kibrit, MK. Yekedüz, EY. Unutmaz, T. Eminoglu, R. Yilmaz, MC. Akbostancı (Ankara, Turkey)

    Objective: To compare patients with Parkinson’s disease (PD, PwP) with and without peptic ulcer disease (PUD) regarding cognition, psychiatric status, motor and non-motor symptoms, mobility,…
  • 2023 International Congress

    Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders Centers

    C. Marras, D. Weintraub, J. Beck, A. Naito, Z. Meyer, N. Dahodwala, T. Davis, K. Mills, J. Miyasaki, S. Mantri, M. Neault, A. Brown, A. Allen, E. Nelson, H. Liu (Toronto, Canada)

    Objective: Implement depression screening using a validated instrument for people with Parkinson’s (PWP) as part of standard of care in the specialist movement disorders setting…
  • 2023 International Congress

    Effects of Boxing and conventional physiotherapy techniques in patients with PD: A randomized control study

    W. Kamel, M. Asala, A. Al-Tajalli, A. Al-Tammar, R. Alkhaldi, C. Ramos Jr, A. Mubarak (beni suef, Egypt)

    Objective: To determine the effectiveness of boxing vs. conventional physiotherapy techniques in improving the quality of movement, motor, cognitive functions in patients with PD. Background:…
  • 2023 International Congress

    Hereditary spastic paraplegia type 4 (SPG4): an international multicenter clinical and genetic study

    A. Orlacchio, E. Panza, R. Rumore, C. Montecchiani, F. Gaudiello, M. Stasi, A. Stigliano, M. Miele, R. Massa, M. Bassi, A. Tessa, F. Santorelli, A. Meyyazhagan, P. St George-Hyslop, J. Pedroso, O. Barsottini, H. Teive, R. Miyamoto, T. Kawarai (Rome, Italy)

    Objective: To describe the epidemiological, clinical, and genetic features of patients affected by hereditary spastic paraplegia (HSP) in an international cohort of affected individuals.To describe…
  • 2023 International Congress

    A non-expensive bidimensional assessment can detect subtle alterations in gait performance in people in the early stages of Parkinson’s disease

    M. Pimentel Piemonte, M. Dalencar, G. Venas, A. Helene, A. Roque, J. Vivas (Sao Paulo, Brazil)

    Objective: To investigate the effectiveness of a two-dimensional gait assessment to identify the decline in gait performance associated with Parkinson's disease progression Background: Gait is…
  • 2023 International Congress

    Prevalence of urinary symptoms and its impact on life quality in patients living with parkinson disease in a mexican population

    A. Herrera Ruiz, D. Aguila-Godinez, M. Ruiz-Mafud, M. Medrano-Delgado, A. Domínguez-García, E. Santiago-Delacruz, A. Regalado-Mustafá, M. Medina-Pérez, L. Lira-Juarez,, G. Hernández-Armesto, K. Talavera-Lagunas, J. García-Hernández, A. Hernández-Medrano, D. Romero-Teran, A. Alcocer-Salas, G. Cerda Hernández, A. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To describe the prevalence and the impact on the quality of life in patients living with Parkinson’s disease with urinary symptoms. Background: Parkinson's disease…
  • 2023 International Congress

    Extended phenotypes of autosomal recessive cerebellar ataxia type 1: learn from a novel mutation of SYNE1 gene

    TL. Lee, CY. Chien, YT. Sun (Tainan, Taiwan)

    Objective: Mutations in the synaptic nuclear envelope protein 1 (SYNE1) gene have been reported to cause ARCA type 1 with a remarkable heterogeneity in clinical…
  • 2023 International Congress

    Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease

    SW. Kang, HS. Yoo, CL. Lyoo (Seoul, Republic of Korea)

    Objective: In this study, we identified specific pattern of cortical atrophy in Parkinson's disease (PD) and investigated whether PD-specific cortical atrophy contributed to motor symptom,…
  • 2023 International Congress

    Clinical accuracy of Medtronic’s Percept built in longevity estimate algorithm following device exchange.

    E. Hargreaves, D. Caputo, D. Dolce, R. Dipaola, S. Danish (Neptune, USA)

    Objective: To examine the accuracy of Medtronic’s Percept built in device longevity estimate. Background: In June of 2020 Medtronic received FDA approval for its Percept…
  • « Previous Page
  • 1
  • …
  • 126
  • 127
  • 128
  • 129
  • 130
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley